EMA Withdrawn: Turvel (trovafloxacin) — Pfizer Limited

View source ↗

Summary

EMA has withdrawn Turvel (trovafloxacin) from the market for bacterial infections after a decision by Pfizer Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Turvel (trovafloxacin)

Snippet

Status: Withdrawn. Therapeutic area: Bacterial Infections. MAH: Pfizer Limited. Decision date: 11/01/2010